(Q38344593)

2 September 2017

title

Absence of short-term effects of glucagon-like peptide-1 and of hyperglycemia on plasma leptin levels in man. (English)

1 reference

2 September 2017

1 reference

Shalev A

1

1 reference

2 September 2017

Vosmeer S

series ordinal

2

1 reference

2 September 2017

Keller U

series ordinal

3

1 reference

2 September 2017

language of work or name

1 reference

1 July 1997

1 reference

2 September 2017

1 reference

2 September 2017

volume

46

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

723-725

1 reference

Weight-reducing effects of the plasma protein encoded by the obese gene

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

A role for glucagon-like peptide-1 in the central regulation of feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Identification and expression cloning of a leptin receptor, OB-R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Lipolytic action of glucagon-like peptides in isolated rat adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990112-8

10.1016/S0026-0495(97)90112-8

7 January 2021

Identifiers

DOI

1 reference

release_yw2p4ald2zeivmcuoptxulxeoi

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yw2p4ald2zeivmcuoptxulxeoi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference